We are headquartered at the Empire State Building in New York City and are investigating Entero Therapeutics, Inc. (NASDAQ: ENTO), relating to the proposed merger with Journey Therapeutics, Inc. Under ...
Entero Therapeutics (ENTO) has entered into a binding term sheet for a reverse merger transaction with Journey Therapeutics. Upon completion of ...
After laying off all nonessential workers and halting nonessential R&D work this summer, Entero Therapeutics is inking a reverse merger with antibody drug conjugate (ADC) rival biotech Journey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback